World News Insights
1-3 Minute Gist

All Topics Article

Cloud Lifted on Angina Drug

Wall Street Journal Original article ›

Keywords:

LyrArc Article Gist
Japanese drug company Astellas makes a $1.1 billion hostile tender offer for California based CV Therapeutics. CV Therapeutics makes an angina drug that recently received FDA approval to isgnificantly ease safety warnings that have been placed on the drug. Astellas is the second Japanese company looking to bolster its drug product line by making an overseas acquisition. Takeda Pharmaceutical acquired Millenium Pharmaceutical for $8.8 billion in 2008.

Acquisitions and acquisition strategies of pharmaceutical companies.

02/09/2006

As growth slows pharmaceutical companies look to acquisitions for growth and new drugs.

Grouped Articles

Indian Drug Maker Vies for Betapharm

Wall Street Journal 02/09/2006

Genentech's Gamble

BusinessWeek 12/05/2007

CEO Says Aging Population Part of Allure of Eye-Care Acquisition

Wall Street Journal 04/08/2008

Pfizer Nears Giant Drug Deal

Wall Street Journal 01/24/2009

Cloud Lifted on Angina Drug

Wall Street Journal 03/02/2009

For Drug Deals, Small Is Beautiful

Wall Street Journal 03/12/2009


Support LyrArc

We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.

Support Lyrarc from as small as $1


Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us